SABS · SAB Biotherapeutics, Inc. · Congressional Trades
$3.16
+0.09 (+2.77%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$285.96M
Shares
90.99M
Volume · Oct 28
157.48K
Avg daily vol (3M)
528.92K
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.